Back to discover
Disease
Superinfection
Emerging research
1
Publications
2021
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- PloS one1
Leading researchers6
- Christensen L1
- Musuuza JS1
- Parmasad V1
- Putman-Buehler N1
- Safdar N1
- Watson L1
Affiliations (unnormalised)2
- University of Wisconsin School of Medicine and Public Health1
- William S. Middleton Memorial Veterans Hospital1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.